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Abstract
ThehepatitisC virus(HCV) p7 protein is criticalfor virusproduction andan attractive antiviral target.p7 isan ionchannel when
reconstituted in artificial lipid bilayers, but channel function has not been demonstrated in vivo and it is unknown whether p7
channel activity plays a critical role in virus production. To evaluate the contribution of p7 to organelle pH regulation and virus
production, we incorporated a fluorescent pH sensor within native, intracellular vesicles in the presence or absence of p7
expression. p7 increased proton (H
+) conductance in vesicles and was able to rapidly equilibrate H
+ gradients. This
conductance was blocked by the viroporin inhibitors amantadine, rimantadine and hexamethylene amiloride. Fluorescence
microscopy using pH indicators in live cells showed that both HCV infection and expression of p7 from replicon RNAs reduced
the number of highly acidic (pH,5) vesicles and increased lysosomal pH from 4.5 to 6.0. These effects were not present in
uninfected cells, sub-genomic replicon cells not expressing p7, or cells electroporated with viral RNA containing a channel-
inactive p7 point mutation. The acidification inhibitor, bafilomycin A1, partially restored virus production to cells
electroporated with viral RNA containing the channel inactive mutation, yet did not in cells containing p7-deleted RNA.
Expression of influenza M2 protein also complemented the p7 mutant, confirming a requirement for H
+ channel activity in
virus production. Accordingly, exposure to acid pH rendered intracellular HCV particles non-infectious, whereas the infectivity
of extracellular virions was acid stable and unaffected by incubation at low pH, further demonstrating a key requirement for
p7-induced loss of acidification. We conclude that p7 functions as a H
+ permeation pathway, acting to prevent acidification in
otherwiseacidicintracellularcompartments.ThislossofacidificationisrequiredforproductiveHCVinfection,possiblythrough
protecting nascent virus particles during an as yet uncharacterized maturation process.
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Introduction
Hepatitis C virus (HCV) primarily infects human hepatocytes
and results in a severe liver disease manifested by chronic
inflammation, progressive fibrosis and development of hepatocel-
lular carcinoma. The virus is highly successful in evading the host
innate and adaptive immune systems [1]. HCV is highly
heterogeneous, leading to genotypic-dependent variations in
pathogenic manifestations and responsiveness to antiviral therapy.
Standard HCV therapy, consisting of interferon and ribavirin, is
only partially successful. Therefore, there is great interest in the
development of new classes of antiviral agents.
The HCV p7 protein is a potential antiviral target. It is not
required for viral RNA replication in cell culture, yet is essential
for HCV infectivity in chimpanzees [2]. It is a member of a class
of viral permeability altering proteins termed ‘‘viroporins’’.
Viroporins are small, virally-encoded proteins that, once
inserted into cellular membranes, homo-oligomerize to form
pores increasing permeability to ions and small molecules [3,4].
In many cases, this channel activity is essential for viral
propagation and infectivity. Other known viroporins include
human immunodeficiency virus type 1 (HIV-1) Vpu, dengue
virus M protein, influenza A virus M2 protein, and poliovirus
2B [3,4]. The p7 protein is a small trans-membrane protein
possessing two hydrophobic membrane-spanning regions sepa-
rated by a short basic loop which is conserved amongst HCV
genotypes [5,6]. HCV p7 forms a multimeric ion channel in
artificial bilayers that is preferentially permeable to cations
[7,8,9] yet has never been shown to act as an ion channel in
biological membranes.
PLoS Pathogens | www.plospathogens.org 1 September 2010 | Volume 6 | Issue 9 | e1001087Viroporins play vital roles in cellular entry and/or exit of several
viruses including the close relative of HCV, bovine viral diarrhea
virus (BVDV), where its homologous p7 protein is required for
infectious virus production [10]. The well characterized M2
viroporin of influenza virus plays roles both during viral entry and
egress. During entry, the M2 proton channel shunts H
+ from the
acidic endosome to the virion interior, initiating uncoating of the
genome and so allowing RNA replication. In certain subtypes, M2
also equilibrates the intraluminal pH of the trans-Golgi network
with the cytoplasm, preventing premature conformational changes
in the viral haemagglutinin (HA) during exit (reviewed in
[11,12,13,14]). While HCV p7 is clearly essential for efficient
infectious particle formation, its exact function in the viral lifecycle
is unknown. Similarly to the situation for M2, p7 has been
proposed to cause a proton (H
+) leak preventing acidification
during the exocytosis of viral particles and we have previously
demonstrated its ability to replace M2 in protecting HA from low
pH [15]. It has thus been suggested that p7 is primarily involved in
the late phase of the virus lifecycle, where it is required for the
efficient release of infectious virions [16]. However, like other
viroporins it is likely that p7 has multiple functions and recent
evidence suggests that p7 may be involved in the earlier stages of
virus production as well [17]. Moreover, mutation complementa-
tion analysis suggests that p7 interacts directly with both other viral
proteins as well as host proteins essential for infectious virus
production [18]. The role of p7 in the HCV lifecycle therefore
remains controversial. This problem is exacerbated by the finding
that amantadine, an inhibitor of the ion channel activity in p7-
containing artificial lipid bilayers, is required at much higher
concentrations to inhibit virus production in culture. It is further
not known whether the presence of p7 is sufficient to alter pH
gradients across intracellular membranes or whether p7 inhibitors
efficiently block this conductance in a native system.
Here, we describe a new method allowing the H
+ conductance
of p7 to be evaluated in native, intracellular membranes and in live
cells. Importantly, we specifically show that this ion channel
activity is necessary for infectious virus production in culture. The
results demonstrate that, when exposed to a sudden pH shift,
intracellular p7-containing vesicles equilibrate pH more rapidly
than vesicles lacking p7, and this activity can be blocked by p7
inhibitors in a genotype-specific manner, as seen previously [19].
The presence of p7 in Huh-7.5 cells resulted in a loss of vesicular
compartment acidification, which was not observed in cells
expressing the inactive p7 mutant, p7K33A/R35A (p7KR).
Furthermore we show that, while viral genomes containing
p7KR are unable to support infectious virus production, infectivity
can be partially rescued either by preventing vesicle acidification
using bafilomycin, or by complementation with influenza A M2
protein. Finally, we show that intracellular infectious virus particles
display greatly increased acid sensitivity compared to extracellular
virions, which were unaffected by incubation at pH 4.0; the same
pH reduced intracellular infectivity by ,100-fold. These data
support the notion that p7 prevents H
+ gradient development and
that this step is a necessary part of the viral lifecycle.
Results
Preparation and pH Indicator Loading of p7-containing
Membrane Vesicles
FLAG-p7 was expressed in 293FT cells and its subcellular
localization was assessed by cell fractionation. Cells were subjected
to differential centrifugation as described in Materials and Methods
yielding a 3,0006g pellet, 3,0006g supernatant and 120,0006g
vesicle pellet. Confirming previous results [20], Fig. 1A, left panel,
demonstrates that p7 was present in the 3,0006g heavy membrane
pellet which also contained endoplasmic reticulum (ER), mitochon-
dria and lysosomes as evidenced by the markers PDI, GRP75 and
LAMP-2. The 120,0006 g light membrane vesicle pellet also
contained p7, lysosomes and ER and was subsequently used to
measure proton (H
+) permeability.
HCV p7 contains two hydrophobic trans-membrane regions
separated by a short basic loop that has been suggested to be
necessary for p7 ion channel activity [15,16] and insertion into
artificial lipid bilayers [21,22]. This loop is conserved amongst
HCV genotypes, further suggesting that it plays a role in p7
function. To confirm that mutation of these residues does not alter
its expression, lysates from FLAG-p7KR mutant-expressing cells
were analyzed. Differential centrifugation of the membrane
fractions showed a similar distribution of the mutant p7 to that
of wild-type p7, showing that mutation of the loop region did not
alter its localization or expression (Fig. 1A, right panel).
In order to measure the proton permeability properties of p7 in
native intracellular vesicles, we used the membrane impermeant
pH-dependent fluorophore 8-hydroxypyrene-1,3,6-trisulfonic acid
(HPTS). This compound can be used as a ratiometric pH indicator
with a near-linear response between pH 7.0 and 8.0 (Fig. 1B).
Isolated membrane vesicles (120,0006g pellet) were loaded ex vivo
with HPTS and purified from free dye using a Bio-Gel P-10 size
exclusion column as described in Materials and Methods. HPTS-
loaded vesicles exited in the void volume and were detected as a
small peak in fluorescence which corresponded to a high molecular
weight protein peak (Fig. 1C, left panel, bars) that exited well before
the bulk of the fluorophore eluted from the column (Fig. 1C, right
panel, circles). Unloaded vesicles had no intrinsic fluorescence (data
not shown). Adding Triton X-100 (final concentration of 0.5%) to
the loaded vesicle homogenate prior to column purification resulted
in complete HPTS release (Fig. 1D). This confirmed the intra-
vesicular localization of fluorophore.
Measurement of Vesicular pH
To assess vesicular H
+ conductance, we measured the
fluorescence response of intra-vesicular HPTS to a sudden
Author Summary
The hepatitis C virus (HCV) is the most common cause of
chronic liver disease. Current therapy is only partially
effective and fraught with side effects. A greater under-
standing of viral replication and new virus particle
formation is thus important for developing new therapeu-
tic targets. The HCV p7 protein is a virally encoded protein
that is absolutely required for the production of new virus
particles. It behaves as an ion channel when reconstituted
into artificial lipid membranes but its function in infected
cells is unknown. We have examined the possibility that p7
functions as an intracellular ion channel, preventing pH
gradients from developing inside the cells. We have shown
that p7 serves this function and it causes a loss of acidity in
multiple intracellular compartments. We demonstrate that
this alkalinization is required for successful virus produc-
tion. Either direct inhibition of intracellular ATPases or
replacement of p7 with an alternative ion channel is able
to compensate for a defect in p7 and allow active virus to
be produced. Therefore, HCV uses p7 to prevent cellular
acidification processes. This understanding will allow for
the targeting of this mechanism with novel therapeutic
agents, and offers new insights into the mechanisms of
liver pathogenesis during infection.
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brane vesicles were pre-equilibrated at pH 7.0 in conductance
assay buffer. Sudden addition of KOH alkalinized the extra-
vesicular space, inducing a rapid pH change from 7.0 to 8.0.
Fig. 2A illustrates the response of HPTS fluorescence ratio to
sudden extravesicular alkalinization. When HPTS was free in
solution, i.e. in the absence of vesicles, (Fig. 2A, circles), the
addition of KOH rapidly alkalinized the solution from pH 7.0 to
8.0. A rapid and immediate increase in fluorescence occurred
within 5 s as a pH of 8.0 was immediately reached. However,
when the HPTS was present within vesicles (Fig. 2A, grey
triangles), KOH addition produced an initial change in pH
followed by a slower equilibration phase whereby the vesicle
interior ultimately reached a steady-state pH of approximately 7.4,
considerably more acidic than the extravesicular solution. This
signal resulted from an intravesicular localization of HPTS
because the fluorescence ratio was not affected by the addition
of a membrane-impermeant fluorescence quencher, p-xylene-bis-
pyridinium bromide (DPX) (Fig. 2A, black triangles). When added
to the extravesicular environment, 15 mM DPX quenched
extravesicular fluorescence, leaving the intravesicular signal intact.
Fig. 2B shows that 15 mM DPX was sufficient to completely
Figure 1. Preparation and pH indicator loading of p7-containing membrane vesicles. HEK-293FT cells were transiently transfected with
either FLAG-p7 or FLAG-p7KR, homogenized 24 h later, and subjected to an initial centrifugation at 3,0006g followed by ultracentrifugation of the
supernatant at 120,0006g.( A) Western blot of the cytosolic extract (3k Sup), heavy membrane fraction (3k Pellet) and light membrane fraction (120k
pellet) showing that FLAG-p7 (left panel) and FLAG-p7KR (right panel) were present in whole cell extracts as well as in the heavy membrane and light
membrane fractions. Marker proteins were LAMP-2 (lysosomal/late endosomal protein), PDI (ER chaperone) and GRP75 (mitochondrial chaperone).
(B) HPTS (100 nM solution) was titrated to varying pH values from 4.5 to 10.5 and fluorescence emission (F) at 520 nm was determined using
excitation wavelengths of 450 and 405 nm. The ratio of F450/405 is presented as a function of pH. Dotted lines represent the linear range. (C) Frozen
120k vesicle pellet was thawed in the presence of HPTS and re-homogenized as described in Materials and Methods. The mixture was applied to a
Bio-Gel P-10 size exclusion column and eluted with constant flow. The column void volume eluted at approximately fraction 28. The right panel
shows both fluorescence and protein content of fractions over the whole column profile while the left panel shows results around the void volume
only with a magnified ordinate. Solid symbols (N) represent fluorescence; bars indicate protein concentration. (D) Protocol was similar to that shown
in C except that the vesicle prep was first exposed to Triton X-100 prior to gel filtration. In this experiment the void volume eluted approximately at
fraction 15. Note the absence of a fluorescence peak associated with the eluted protein.
doi:10.1371/journal.ppat.1001087.g001
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HPTS in free solution. This confirms that the addition of DPX
fully quenches extravesicular HPTS. Furthermore, rapid and full
equilibration to pH 8.0 occurred after disruption of vesicles by
Triton X-100 (data not shown).
We postulated that vesicles prepared from normal 293FT cells
might have delayed pH equilibration with the external solution
because H
+ conductance was rate limiting in the face of ionic
transport processes that tended to produce a net acidification. To
test this hypothesis we examined the effect of a proton ionophore
on pH equilibration in this system. The addition of FCCP
(carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone) imme-
diately prior to vesicle alkalinization resulted in a more rapid
intravesicular pH rise that reached full equilibration with the
Figure 2. Measurement of Intravesicular pH. HPTS-loaded vesicle suspensions or HPTS solution without vesicles were subjected to rapid
alkalinization by sudden injection of 10 ml of 50 mM KOH into a total volume of 100 ml. Fluorescence ratio (F450/F405) and corresponding pH was
measured at 1 s intervals in a fluorescence plate reader. (A) Comparison of pH changes of HPTS in free solution (gray circles) vs. in suspensions of
HPTS-containing vesicles (gray triangles). Free solution rapidly equilibrated to pH 8.0 while vesicles alkalinized more slowly and failed to equilibrate
with the extravesicular solution pH during the observation period. Inclusion of DPX, a membrane impermeant fluorescence quenching agent (black
triangles) did not affect intravesicular pH changes. (B) Effects of DPX on extracellular solution fluorescence. Absolute fluorescence, F450, was
measured in HPTS solution before and after alkalinization. The presence of DPX (15 mM) completely quenched fluorescence of this fluorochrome. (C)
Steady state pH values measured at 240 s from a series of experiments performed as in panel A. Data is presented as mean 6 SE, n=4 independent
vesicle preparations. (D) Measurement of the effect of the protonophore FCCP on intravesicular pH changes. HPTS-loaded vesicles were incubated
with or without FCCP (4 mM) added either immediately prior to (red line) or 4 min after (green line) the pH shift. FCCP had no effect on free solution
pH as shown in the black and grey curves. (E) Steady state pH values as described for panel C. n=4 independent membrane preparations. * indicates
P#0.05 compared to control vesicles.
doi:10.1371/journal.ppat.1001087.g002
HCV p7 Proton Conductance and Virus Production
PLoS Pathogens | www.plospathogens.org 4 September 2010 | Volume 6 | Issue 9 | e1001087extravesicular solution (Fig. 2D–E, red). Furthermore, addition of
FCCP during the period of pH equilibration caused a rapid
alkalinization to full pH equilibrium (Fig. 2D–E, green). As
expected, FCCP had no effect on HPTS fluorescence in bulk
solution. This demonstrates that H
+ efflux is limited by the
intrinsic H
+ permeability/conductance of the membrane in these
vesicles.
Conductive Properties of p7 Proteins from Different HCV
Strains Expressed in Native Intracellular Membranes
p7 sequences have been suggested to promote virus production
in a genotypic-specific manner [16], however it is unknown if this
is related to ion channel function. We therefore examined the
ability of p7 proteins from different HCV genotypes to alter
membrane H
+ permeability. Native intracellular membrane
vesicles (120,0006 g pellet) expressing either genotype 1b (J4
isolate, ‘‘FLAG-p7’’) or 2a (JFH-1 isolate, ‘‘FLAG-JFH1p7’’) p7
displayed a significant increase in H
+ permeability when compared
to vesicles from control cells (Fig. 3) and stabilized at an intra-
vesicular pH of approximately 8.0. The addition of FCCP had no
additional effect on the efflux of H
+ from p7-containing vesicles
showing that conductive H
+ flux was no longer rate limiting for
pH equilibration.
The membrane spanning domains of p7 are separated by a
basic loop which is conserved amongst HCV genotypes further
suggesting it plays a role in p7 function. We have previously shown
that mutating these basic residues to alanine (FLAG-p7K33A/
R35A mutant and FLAG-JFH1p7R33A/R35A mutant) renders
p7 incapable of protecting HA from acidic pH [15], or serving as a
permeation pathway in in vitro liposome-based assays for channel
function [22]. Yet its direct effect on p7-induced H
+ permeability
is unknown. Vesicles isolated from cells expressing the mutated
FLAG-p7KR or FLAG-JFH1p7RR displayed a H
+ conductance,
similar to that of control vesicles from untransfected 293FT cells.
Furthermore, the addition of FCCP was still able to restore rapid
and full pH equilibration demonstrating that the failure of the
mutant p7 to cause rapid pH equilibration was due to a lack of an
effect on proton conductance. This result indicates that these




+ Conductance is Sensitive to Known
Viroporin Inhibitors
Several viroporin inhibitors have been shown to abolish p7
ion channel activity in artificial lipid bilayers [7–9], as well as to
inhibit infectious particle production in a genotype-dependent
manner [19]. However, it is not known whether they func-
tion to block intracellular H
+ conductance. To confirm the
specificity of our observation that p7 induces a significant H
+
conductance, we assessed the effect of several candidate p7
inhibitors. Vesicles incubated with 1 mMa m a n t a d i n e ,a
concentration shown to inhibit p7 in artificial bilayers
[7,22,23] as well as specifically inhibit the M2 viroporin of
influenza [13,24], reduced the H
+ conductance induced by the
J4/1b p7 to that of control vesicles (Fig. 4A). Inhibition of J4/
1b p7 H
+ conductance was also seen with the amantadine
derivative, rimantadine, as well as hexamethylene amiloride
(HMA). In agreement with our previous observations in vitro
and in the context of infectious virus [19], inhibitor sensitivity
varied according to p7 sequence; H
+ conductance induced by
the JFH1/2a p7 was eliminated by rimantadine and HMA, yet
was insensitive to amantadine (Fig. 4B). The addition of FCCP
induced an H
+ conductance despite the presence of these
inhibitors, indicating that the compounds did not alter vesicle
stability or have a direct effect on HPTS fluorescence (data not
shown).
Figure 3. Conductive properties of HCV p7 proteins. Vesicle pellets were isolated from HEK-293FT cells that were transfected with either
genotype 1b p7 (J4 sequence), genotype 2a p7 (JFH1 sequence), the corresponding channel inactive mutants p7K33A/R35A (p7KR) and p7R33A/
R35A (p7RR) or mock control vector. Vesicles were loaded with HPTS as described in Materials and Methods and subjected to rapid alkalinization by
sudden injection of KOH at time zero according to the protocol shown in Fig. 2. Where indicated, FCCP (4 mM) was added immediately prior to the
addition of KOH. (A) A single representative experiment is shown demonstrating the time course of intravesicular pH changes in control, p7- or
mutant p7-expressing vesicles. (B) The average steady state pH change at 200 s was determined as in A, in response to extravesicular alkalinization.
Data is presented as mean 6 SE. n = a minimum of 6 independent vesicle preparations for each condition. * indicates P#0.05 compared to control
vesicles with no FCCP.
doi:10.1371/journal.ppat.1001087.g003
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Cells
To overcome limitations presented by a transfection-based
system, an HCV replicon system was utilized. We studied Huh7-
derived cell lines harboring RNAs from a third HCV genotype 1a
strain (H77) [25,26]. Replicon cell lines contained stably replicating
sub-genomic RNA (NS2 – NS5b) or full-length RNA (Core –
NS5b). A cured full-length replicon cell line, in which the HCV
RNA had been eliminated by prior treatment with interferon,
served as a control. The response to a trans-vesicular pH gradient
was greatly enhanced in vesicles prepared from cells containing the
full-length replicon, which rapidly equilibrated to pH 8.0, when
compared to the cells containingthe sub-genomic replicon that does
not express p7 (Fig. 5, A–B). Vesicles isolated from the cured
replicon cells displayed a similar conductance pattern as the vesicles
isolated from sub-genomic replicon cells. Isolated full-length
replicon cell vesicles also showed specific viroporin-mediated H
+
permeability; as seen previously [19], the H77 p7-induced H
+
conductance was inhibited by amantadine, rimantadine and HMA.
Pretreatment of vesicles from full-length replicon cells with 1 mM
inhibitor resulted in almost 100% inhibition of H
+ conductance.
p7 thus functions as proton permeation pathway in vesicles
prepared from native, intracellular membranes and has inhibitor
sensitivities identical to those determined in bilayers and artificial
liposomes [19]. To determine if this activity is present in live cells,
we incubated replicon cells with LysoSensor Yellow/Blue DND-
160, a pH probe that exhibits a pH-dependent shift in fluorescence
upon acidification. As shown in the calibration curve in Fig. 5C,
LysoSensor Yellow/Blue DND-160 can be efficiently used to
monitor intracellular vesicular pH of live cells. Live cell ratiometric
imaging of HCV replicon-bearing cells showed punctuate vesicles
of varying size (Fig. 5D). Cells containing full-length HCV replicon
RNAs, expressing p7, had a net alkalinization of these vesicular
structures and an average vesicular pH of nearly 6.0, whereas both
sub-genomic and cured cells possessed an intra-vesicular pH of
approximately 4.5 (Fig. 5D–E).
To confirm these results with an alternate pH probe, we used
LysoTracker Red DND-99, a fixable fluorescent probe that has
high selectivity for acidic organelles. Once inside acidic compart-
ments, this fluorophore will fluoresce red while more neutral
compartments will remain non-fluorescent. We found that cells
containing the replicating full-length HCV RNA demonstrated a
significant loss in acidic organelle staining with punctuate red
fluorescence (Fig. 5F–G) compared to both sub-genomic and
cured HCV replicon cells. These data strongly support the notion
that p7 acts as a pH equilibrating H
+ channel in vivo.
p7 Induces Channel Activity within Infected Cells
Given that p7 acts as a H
+ channel in cells containing HCV
replicons, we sought to determine whether this conductance was
also present during HCV infection. Huh-7.5 cells were infected
with the parental HJ3-5 virus at an MOI of 0.1, and stained with
LysoTracker Red DND-99 to label acidic compartments. Infected
cells were identified by immunofluorescence staining for core
protein. Infection of Huh-7.5 cells with HJ3-5 resulted in a global
loss of highly acidic organelles and compartments (Fig. 6A-B,
HCVcc). To ensure that the loss of acidic structures seen during
HJ3-5 infection was due to p7 activity, we tested the effect on pH
equilibration following electroporation of cells with either HJ3-5
RNA containing the wild-type or mutant p7KR sequence (Fig. 6).
Unlike the parental HJ3-5 viral RNA, the p7KR mutant was
unable to alter intracellular pH, confirming that p7 acts as a
proton channel during HCV infection.
Effects of Viroporin Inhibitors on Vesicular pH and
Infectious Virus Production
We have shown that the channel activity of J4/1b, JFH-1/2a
and H77/1a p7 proteins, when present in isolated membrane
vesicles, is blocked by several viroporin inhibitors including
amantadine and rimantadine. However, p7 channel inhibitors
have yet to demonstrate clinical efficacy in the treatment of
chronic hepatitis C, suggesting the possibility that the channel
Figure 4. Sensitivity of p7-associated pH changes to known viroporin inhibitors. HPTS loaded vesicles were subjected to rapid
alkalinization by sudden injection of KOH as described for Figs. 2 and 3. The H
+ conductance induced by the J4/1b p7 (A) and JFH1/2a/p7 (B) was
inhibited by several viroporin inhibitors. Data is presented for each of the two genotypes as mean 6 SE of the steady state pH change observed in
control, p7-expressing vesicles (WT) and in p7 containing vesicles in which inhibitor compounds (1 mM) were added immediately prior to the pH shift.
Ama = amantadine, Rim = rimantadine and HMA = hexamethylene amiloride. n = a minimum of 3 independent vesicle preparations. * indicates
P#0.05 compared to control, ** indicates P#0.05 compared to wild-type.
doi:10.1371/journal.ppat.1001087.g004
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We therefore examined whether the p7 effects on vesicular pH in
live cells could be reversed by channel inhibitors. Full-length
replicon cells were loaded with LysoSensor Yellow/Blue DND-
160 and treated with either amantadine or rimantadine. As shown
previously, basal vesicular pH of full-length replicon cells was
nearly 6.0, markedly more alkaline than sub-genomic or cured
full-length replicon-bearing cells (Fig. 7A–B). Treatment of full-
length replicons with increasing concentrations of both amanta-
dine and rimantadine was able to partially restore vesicular acidic
pH within 5 min of treatment while sub-genomic replicons and
cured cells were unaffected by inhibitor treatment. Consistent with
Figure 5. Effect of p7 on intracellular pH in HCV replicon-bearing cells. Intravesicular pH was measured in vesicles isolated from HCV
replicon bearing cells that were subjected to rapid alkalinization as shown for Fig. 2. (A) A single representative experiment is shown demonstrating
the time course of intravesicular pH changes in vesicles isolated from full-length (FL), sub-genomic (SG) and cured full-length (CFL) HCV replicons.( B)
The average steady state pH change at 180 s in response to extravesicular alkalinization was determined. Data is presented as mean 6 SE. n = a
minimum of 6 independent vesicle preparations for each condition. Inhibitor compounds were added immediately prior to the pH shift as in Fig. 4.
* indicates P#0.05 compared to control, ** indicates P#0.05 compared to full-length. (C) Free solution calibration of LysoSensor Yellow/Blue DND-
160. Fluorochrome (100 nM) was dissolved in HEPES solution and titrated to various pH values. Aliquots (750 ml) were placed in a 25 mm cover slip
chamber and the fluorescence was measured using a Nikon TiE fluorescence microscope at excitation 380 emission 525 (wavelength 1) and excitation
340 emission 440 (wavelength 2). Ratio is presented as wavelength 1/wavelength 2. (D) Sub-genomic (SG), full-length (FL) and cured full-length (CFL)
HCV replicon bearing cells were loaded with the ratiometric pH sensor, LysoSensor Yellow/Blue DND-160, and imaged at the 2 wavelength pairs used
for the calibration in panel C. Fluorescence ratio images are presented where the fluorescence ratio at each pixel was mapped to a pseudocolor
representation based on the calibration curve. (E) Mean vesicular pH as determined from the fluorescence ratio images in multiple experiments as in
panel D is shown. Data is presented as mean 6 SE of cytosolic fluorescence ratio with the corresponding pH scale indicated on the right. Data
represents the average of 25 cells in each of 4 independent cell preparations with the mean of each individual cell preparation counting as n=1.
* indicates P#0.05 compared to sub-genomic replicons. Scale bar represents 20 mm. (F) Presence of highly acidic organelles was assessed in HCV
replicon-bearing cells by incubation for 30 min with LysoTracker Red DND-99 (100 nM). Nuclei were counterstained with DAPI. Excitation and
emission wavelengths for LysoTracker Red were excitation 560 nm and emission 607 nm, represented as red, and excitation 380 nm and emission
440 nm for DAPI, represented as blue. Acidic organelles appear as red structures. Scale bar represents 20 mm. (G) Total LysoTracker cellular
fluorescence for experiments conducted as in panel F is shown. Data are presented as mean 6 SE of total cellular LysoTracker fluorescence. Data
represents the average of at least 25 cells in a minimum of 3 independent cell preparations with the mean of each individual cell preparation counted
as n=1. * indicates P#0.05 compared to sub-genomic replicons.
doi:10.1371/journal.ppat.1001087.g005
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inhibitor (EC50<15 mM) than amantadine (EC50<75 mM), but in
both cases, the concentration required to alter channel function in
live cells was considerably higher than for isolated membrane
vesicles, and full restoration of acidic compartments was not
achieved. Rimantadine was able to re-acidify vesicular compart-
ments to approximately pH 5.0 and amantadine to roughly 5.5
(Fig. 7B).
To explore the involvement of p7 H
+ channel activity in virus
production, we examined whether a direct correlate existed
between the re-acidification achieved by blocking p7 channel
activity with specific inhibitors and the observed reduction in
infectious virus production and/or release. Huh-7.5 cells were
infected with HJ3-5 virus and cultured in medium supplemented
with varying concentrations of amantadine as described in
Materials and Methods. Fig. 7C–D shows the titer of infectious
virus released into the extracellular supernatant as well as the ratio
between intracellular and extracellular virus after amantadine
treatment. Consistent with replicon LysoSensor studies, amanta-
dine at 1 mM, a concentration that nearly completely blocked p7-
induced H
+ conductance in isolated vesicles, had no effect on the
release of infectious virus (Fig. 7C, bars), Yet, similar to previous
results with both amantadine and rimantadine [19], increasing
concentrations of amantadine reduced the release of infectious
virus. Interestingly, the ability of amantadine to block virus
production correlated directly with its ability to reverse the p7-
induced loss of acidic intra-organelle pH (Fig. 7C, compare line
and bars). As previously reported, treatment with 100 mM
amantadine for 24 h did not result in any cellular toxicity [19].
This result confirms the existence of a relationship between the
antiviral effect of amantadine and its ability to specifically inhibit
intracellular p7 channel activity.
p7 Channel Activity is Required for Production of
Infectious Virus
To definitively determine whether the p7-induced loss of vesicle
acidification contributes to infectious virion production, we deter-
mined whether preventing this acidification pharmacologically using
the vATPase inhibitor, bafilomycin A1, could compensate for the
p7KR defect. To perform this experiment it was necessary to first
confirm that vesicular acidification could be inhibited without cellular
toxicity or interference with the ability to assay for infectious virus.
Figure 6. p7 channel activity within infected cells. (A) Huh-7.5 cells were infected with HJ3-5 virus (HCVcc) or electroporated with parental HJ3-
5 or mutant HJ3-5(KR) HCV RNA and assayed after 3 days. Cells were subsequently incubated with LysoTracker Red DND-99 as described in Materials
and Methods and viral replication was detected by immunostaining for core protein (green). Representative images showing both infected and non-
infected cells are shown for each condition. Scale bar represents 20 mm. (B) Mean 6 SE of total cellular LysoTracker fluorescence. Total magnitude of
red fluorescence was calculated separately for non-infected cells and for cells infected with each of the different virus constructs as described for
Fig. 5G. Data represents the average of at least 6 cells in each of 4 independent cell preparations with the mean of each individual cell preparation
counted as n=1. * indicates P#0.05 compared to uninfected cells.
doi:10.1371/journal.ppat.1001087.g006
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A1 affects vesicular acidification, virus entry and cell death as
described in Materials and Methods (Fig. 8A–C). At 2.5 pM,
bafilomycin A1 was not cytotoxic, did not significantly inhibit viral
entry, yet significantly alkalinized vesicular acidic compartments to a
similar extent as seen during HJ3-5 infection where an alternative pH
sensitive fluorochrome of similar pKa value was used.
Huh-7.5 cells were then electroporated with the parental HJ3-5
virus RNA, the channel-inactive p7 mutant, HJ3-5(KR), or an
RNA in which the p7 sequence had been removed by an in-frame
deletion, HJ3-5(Dp7). After four days, the media was replaced with
fresh media containing 2.5 pM bafilomycin A1. Twenty-four
hours later, the cells were harvested and the titer of both intra- and
extracellular infectious virus was determined by inoculation onto
Figure 7. Effects of viroporin inhibitors on intracellular vesicular pH and infectious virus production. (A) The ability of inhibitors to
affect p7 channel function in vivo was assessed in full-length replicon bearing cells loaded with LysoSensor Yellow/Blue DND-160. Amantadine or
rimantadine were added directly to LysoSensor loaded cells and the cells were imaged after 5 min. Fluorescence ratio images are presented as for
Fig. 5D and pH is represented by pseudocolor mapping as indicated. Scale bar represents 20 mm. (B) Average pH changes from a minimum of 3
experiments performed as in panel A. pH values were determined from fluorescence ratios by interpolation on the calibration curve as shown in Fig. 5.
FL = full-length, SG = sub-genomic and CFL = cured full-length HCV replicons. (C) Comparison of the effect of various concentrations of
amantadine on both intravesicular pH (data from panel B) and infectious virus present in the extracellular culture medium. For measurement of virus
titers, Huh-7.5 cells were incubated with the indicated concentration of amantadine for 24 hours prior to collection of medium and tittering by the
FFU assay as described in Materials and Methods. (D) Intra- and extracellular infectious virus production after amantadine treatment. Huh-7.5 cells
were infected with HJ3-5 virus and treated with amantadine as described in Materials and Methods. Medium was collected for determination of
infectious virus titer by FFU assay (Extracellular), and cell pellets were washed, disrupted by freeze-thaw and then assayed similarly (Intracellular). Bars
represent the proportion of the total infectious virus yield that was present in each compartment.
doi:10.1371/journal.ppat.1001087.g007
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rated with the parental HJ3-5 virus RNA had no effect on the
production of infectious virus, as intra- and extracellular virus
titers remained ,10
3 and ,10
4 FFU/ml, respectively (Fig. 8D–E).
As expected, cells electroporated with either the mutant HJ3-
5(KR) or HJ3-5(Dp7) RNAs showed no evidence of either
extracellular or intracellular infectious virus production. However,
treatment with 2.5 pM bafilomycin A1 was able to partially rescue
infectious virus production by the KR mutant, resulting in
approximately 10
2 FFU/ml in both the intracellular and
extracellular compartments. Replication foci were noticeably
smaller in cells inoculated with the rescued HJ3-5(KR) virus
compared to the parental virus, consistent with a defect in cell-to-
cell spread of virus within the naı ¨ve cells in the absence of drug
treatment. Antibody to CD81 prevented infection by this HJ3-
5(KR) virus, suggesting that it enters cells via the well
characterized HCV receptor mechanism (data not shown). These
results thus demonstrate that p7 H
+ channel activity is essential for
the production of infectious HCV, both within the cell and in cell
culture supernatant fluids. Importantly, infectious virus production
Figure 8. Bafilomycin A1 rescue of infectious virus production. (A) Concentration dependence of bafilomycin A1 on intravesicular pH in Huh-
7.5 cells. Cells were loaded with the single wavelength pH indicator, LysoSensor Green DND-189, and treated with various concentrations of
bafilomycin A1 as indicated. The increase in vesicular pH was measured as a decrease in fluorescence intensity at Ex/Em 443/510. Each data point
represents mean 6SE from a minimum of 10 cells. (B) HCVcc (MOI 1.0) was used to infect naı ¨ve Huh-7.5 cells in the presence of varying
concentrations of bafilomycin A1. Cells were then fixed and immunostained for core protein 3 days later. Relative infectivity was determined by
measuring the intensity of core immunostaining normalized to cell number (see methods). (C) Cytotoxicity of bafilomycin A1 in Huh7.5 cells. Cells
were cultured in the presence of various concentrations of bafilomycin A1 for 72 hrs. Cell viability was determined using CellTiter-Blue Reagent (see
methods). Data are presented as the number of live cells, with untreated (no bafilomycin A1) set to 100%. (D) Huh-7.5 cells were electroporated with
parental HJ3-5, mutant HJ3-5(KR) or HJ3-5(Dp7) HCV RNA and allowed to grow for 96 h. The cells were then treated with 2.5 pM bafilomycin A1 for
24 h after which time, intra and extracellular virus was collected and used to infect naı ¨ve Huh-7.5 cells as described in Materials and Methods. Wild-
type virus supernatants were diluted 10-fold, KR and Dp7 supernatants were undiluted. These cells were immunostained for core protein (green).
Example images of the formation of FFUs in each condition are presented. The scale bar represents 200 mm. (E) Titers of intra- and extracellular virus
production in the presence or absence of 2.5 pM bafilomycin were determined from 4 experiments conducted as in panel D. No FFU were detected
in the KR virus in the absence of bafilomycin in any of the experiments. (F) Western blot for the presence of core protein in whole cell lysates
prepared from Huh-7.5 cells electroporated with WT (HJ3-5), KR (HJ3-5(KR)) or Dp7 (HJ3-5(Dp7)) HCV RNA.
doi:10.1371/journal.ppat.1001087.g008
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bafilomycin A1 treatment, suggesting that other, non-H
+ channel
p7 functions are likely to be required for the assembly and release
of infectious virus. Equal expression of HCV core protein was
detected for each of these viral constructs, indicating that each of
these RNAs is capable of replicating following electroporation into
cells (Fig. 8F).
Influenza M2 protein Can Trans-complement an HCV p7
Channel Mutant
As bafilomycin A1 partially rescued infectious virus production
for the channel-inactive p7KR mutant, we investigated whether
the influenza A M2 (IAV M2) proton channel might act similarly.
We first examined the ability of M2 to alter pH gradients in live
cells. Huh-7.5 cells were transfected with M2 or the channel
inactive M2, M2(A30P) [27] and loaded with LysoSensor Yellow/
Blue DND-160. The presence of M2 caused a net alkalinization of
highly acidic vesicular structures measuring an average pH of 5.5
while cells expressing an empty vector or the channel inactive
M2(A30P) measured an intravesicular pH of approximately 4.3
(Fig. 9A).
To assess whether M2 H
+ channel activity was specifically able
to rescue a p7-deficient HCV, we exploited the genotype-
dependent sensitivity of p7 to amantadine. Thus, we assessed the
ability of an amantadine-sensitive M2 protein to rescue the
amantadine resistant genotype 2a JFH-1 HCV, thereby utilizing
amantadine sensitivity to identify an M2-specific effect. Huh-7.5
cells were co-electroporated with plasmids encoding the amanta-
dine-sensitive IAV M2 protein or the channel inactive M2,
M2(A30P), along with wild-type JFH-1, JFH-1(RR) or polymerase
mutant, JFH-1(GND) RNA. Following amantadine treatment,
yields of extracellular infectious virus were assessed. Cells
electroporated with JFH-1 RNA produced approximately 10
4
FFU/ml and the release of infectious virus from JFH-1-
electroporated cells was not affected by the expression of M2,
M2(A30P) or the presence of 50 mM amantadine (Fig. 9B). JFH-
1(RR) RNA produced no detectable infectious virus, however, co-
electroporation of JFH-1(RR) and IAV M2 resulted in a partial
rescue of infectious virus production, yielding between 10
3 and 10
4
FFU/ml. Unlike JFH-1 infected cells, however, the release of
infectious virus by the M2 trans-complemented JFH-1(RR) mutant
was partially inhibited by amantadine. In addition, the M2
mutant, M2(A30P) was unable to rescue the JFH-1(RR) mutation.
This result confirms the requirement for H
+ channel activity for
virus production from the HJ3-5 chimeric virus in which the p7
sequence is of genotype 1a origin.
Exposure to Acidic pH Renders Intracellular Infectious
Virus Non-infectious
We have shown that p7 can dramatically alter the pH of
intracellular compartments and that this vesicular alkalinization is
required for infectious virus production. While it has previously
been shown that mature HCV particles are acid resistant, we
hypothesized that intracellular infectious virus particles might be
acid sensitive and that p7-induced alkalinization could protect
them from an acid milieu. To examine this, we isolated both
extracellular and intracellular virus and exposed them to acidic
solutions. Huh-7.5 cells were infected with cell culture passaged
JFH-1 virus. After five days, both extracellular and intracellular
virus was harvested and incubated for 10 min at 37uC in identical
HEPES/MOPS buffer solutions to achieve final pH values of 7.0,
6.0, 5.0, and 4.0. This solution was then neutralized back to
pH 7.0 and used to inoculate naı ¨ve Huh-7.5 cells. Infectious titer
was determined by the standard FFU assay. Similarly to what has
Figure 9. Influenza M2 protein can trans-complement an HCV p7 channel mutant. (A) Huh-7.5 cells were loaded with the ratiometric pH
sensor LysoSensor Yellow/Blue DND-160 and imaged as described in Materials and Methods. Mean vesicular pH as determined from the fluorescence
ratio in multiple experiments is shown. Data is presented as pH 6 SE. Data represents the average of 20 cells in each of 3 independent cell
preparations with the mean of each individual cell preparation counting as n=1. * indicates P#0.05 compared to empty vector. (B) Huh-7.5 cells
were co-electroporated with mCherry-M2 or the channel inactive mCherry-M2(A30P) and one of three HCV RNAs: wild-type JFH-1, channel inactive
JFH-1(RR) or polymerase null JFH-1(GND) HCV RNA as described in Materials and Methods. Supernatants were collected and assayed for infectious
virus titer by FFU determination. Where indicated, cells were treated with 50 mM amantadine for the final 24 hrs prior to harvesting the medium. Data
are represented as mean 6 SE from three independent experiments.
doi:10.1371/journal.ppat.1001087.g009
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infectivity was unaffected when the virions were exposed to pH
values as low as 4.0 (Fig. 10). However, intracellular infectious
virions displayed greatly increased acid sensitivity, with nearly a 2
log10 decrease in infectivity at pH 4.0.
Discussion
HCV p7 is required for infectious particle formation and plays a
role during virion egress [16,17]. Convincing data shows that it
forms ion channels in artificial lipid bilayers [7,8,9,29] yet,
whether ion channel activity is required by the virus, or whether
p7 functions as a channel at all inside infected cells has remained
unknown. In the present study we evaluated the ability of p7 to
facilitate equilibration of intracellular pH gradients and examined
its contribution to the production of infectious virus. We
demonstrate that p7 mediates proton (H
+) equilibration in isolated
vesicles as well as in Huh7 cells in vivo. Its presence results in a loss
of intracellular compartment acidification, and this reduction in
acidification is required for the production of infectious virus.
While mature virions are acid stable, intracellular virus can be
inactivated by acidic pH. In the absence of a functional p7
channel, alternative methods to alkalinize intracellular compart-
ments can partially rescue infectious virus production.
Native vesicles without p7 expression showed a low permeability
for H
+ as evidenced by slow and incomplete pH equilibration
upon exposure to a shift in extravesicular pH. When exposed to a
sudden pH shift, they slowly equilibrate pH and fail to fully
equilibrate over a 3 min period. In contrast, vesicles derived from
cells expressing p7 from genotypes 1a, 1b or 2a HCV were capable
of rapid pH equilibration, similar to normal vesicles in the
presence of FCCP. This effect was inhibited in a genotype-specific
manner [19] by amantadine, rimantadine and hexamethylene
amiloride, and was not observed with channel-inactive p7 variants
expressed to comparable levels.
To determine the extent to which p7 alters cellular ionic
homeostasis, we utilized two fluorometric pH sensors that serve as
pH reporters in live cells but work by different mechanisms.
LysoTracker Red DND-99 is an acidotropic probe with high
selectivity for acidic organelles. Although its fluorescence is largely
independent of pH, it can be fixed with paraformaldehyde and
serves to mark the presence of highly acidic organelles. LysoSensor
Yellow/Blue DND-160 is a ratiometric pH sensor. It concentrates
in organelles with less pH sensitivity, but undergoes a pH-
dependent fluorescence spectrum shift that can be used to directly
measure pH. Each fluorophore showed that the expression of the
HCV p7 protein by replicon RNAs or during infection resulted in
an alkaline shift of organelle pH and a dramatic reduction in the
number of highly acidic intracellular compartments. This loss of
organelle acidity only occurred in HCV infected or p7-containing
cells and did not occur with electroporation of viral RNA
containing the inactive channel mutant, p7KR. It was notable
that loss of acidification was not restricted to one location or
structure in the cell and seemed to be a global effect. To our
knowledge, this is the first time a viroporin has been shown to
directly induce a global loss in organelle acidity.
Our results show that the p7-associated proton conductance is
inhibited by the viroporin inhibitors, amantadine and rimanta-
dine. However, it is worthy to note that these channel blockers had
very different concentration dependence in isolated vesicle systems
compared with live cells. In vesicles, our results confirmed most of
what has been reported for bilayers and artificial liposomes [23].
Both amantadine and rimantadine were effective at concentrations
of 1 mM for genotype 1a p7 and only rimantadine was effective as
a channel blocker at 1 mM for genotype 2a p7. However, in live
cells we observed a different concentration dependence. We found
that amantadine did not affect or restore vesicular acidity at
concentrations lower than 50 mM. Rimantadine was effective at
concentrations approximately 5-fold lower. The reason for the
difference between isolated vesicles and cells is not clear but could
be due to limited entry into cells, active cellular extrusion or
intracellular binding of the compounds.
Multiple lines of evidence demonstrate that the p7-induced loss
of acidification is necessary for the production of infectious virus.
First, while we confirmed that the mature HCV virions are acid
stable, intracellular virus is not and therefore there appears to be a
phase during maturation in which protection from an acid
environment is required. This idea is further supported by the
observation that concentrations of the V-ATPase inhibitor
bafilomycin A1, sufficient to raise the pH of acidic organelles,
partially rescued infectious virus production in the null p7KR
phenotype. Virus produced from the p7KR mutant virus, as a
result of bafilomycin rescue, was subsequently able to enter cells by
the normal viral receptor-mediated entry pathway which was
inhibited by anti-CD81 antibody. This suggests that p7 may not be
required for viral entry. A second line of evidence in support of a
role for p7 channel activity in infectious virus production was the
observation that the JFH-RR mutant virus could be rescued by
expression of influenza A M2 protein. This viroporin has been
shown to be a proton equilibrating channel in the secretory
pathway [12,13], but is unlikely to be able to trans-complement
other potential HCV p7 specific functions such as viral protein-
protein interactions.
A third line of evidence that supports an ion channel function
for p7 in virus production is the correlation between the effects of
amantadine on intravesicular pH and virus production. As shown
in Fig. 7, amantadine did prevent virus production but only at the
concentrations at which it was effective as an intracellular channel
inhibitor in live cells. Previous studies examining the effect of
amantadine on the HCV p7 protein have been difficult to
reconcile. Amantadine inhibits the genotype 1 p7 channel in
bilayers at low micromolar concentrations, but it does not inhibit
virus production until 50–100 mM [7,19], and it has failed to have
Figure 10. Intracellular infectious virus is acid sensitive. Huh-7.5
cells were infected with JFH-1 virus. After five days, cell culture
supernatants (extracellular virus) and freeze-thaw lysates (intracellular
virus) were collected and diluted 1:1 in MES/HEPES buffer to give final
pH values of 7, 6, 5 and 4. After a ten min incubation at 37uC, the viral
titers were determined by FFU assay. Data are represented as mean 6
SE from three independent experiments.
doi:10.1371/journal.ppat.1001087.g010
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concentrations of 1–2 mM are the highest that can be achieved
[30]. Our results in live cells, however, clearly show that higher
extracellular concentrations of amantadine are required to restore
the acidic pH of intracellular vesicles in p7 expressing cells.
Furthermore, this effect has the same concentration dependence as
does inhibition of virus production, thus implying a direct role of
p7 channel activity in virus production and supporting that
amantadine would have a specific antiviral effect in vivo should it
reach sufficient local concentration.
A notable finding in this study is that bafilomycin A1 was able to
partially overcome the defect in the KR mutant but was not able to
complement a p7 deletion mutant. This suggests that p7 has
additional effects unrelated to its channel activity. Recent structural
analysisshowsthattheJFH-1p7proteinformsahexamericstructure
withaluminally-facing,openorientation[31].Thisexposedregionis
then available to provide protein-protein interaction sites. Similarly,
this is seen with HIV-1 where its viroporin, Vpu, promotes HIV-1
infectivity and release of infectious virus particles through protein-
protein interactions with the host such as sequestration of the virus
receptor CD4 and hindering of BST-2/tetherin [32]. This supports
previous data for HCV showing that incompatibilities in the
sequence of NS2 in inter-genotypic HCV chimeras that limit
RNA replication can be overcome by spontaneous, compensatory
mutationsinp7,thusprovidinggeneticevidencethatcriticalprotein-
protein interactions exist between p7 and other non-structural
proteins [17,18]. Overall, this suggests that p7 has additional
functions unrelated to its channel activity. The KR mutant protein
may serve these other functions and therefore can be rescued by pH
manipulation, but the total absence of p7 produces more profound
defects that cannot be overcome by pH changes alone. It was
recently reported that the influenza M2 protein was not able to
complement the absence of p7 in a novel trans-complementation
system using a helper replicon to express the complementing protein
[33]. Using a similar construct that we used in our Dp7 experiments,
thisstudyshowedthataDp7-halfdeletioncouldbecomplementedto
varying degrees by p7, E2p7, and E2p7NS2, but not by M2. If p7
performs distinct channel-dependent and channel independent
functions, then logically M2 would not be expected to restore virus
production to the p7-deleted virus as it would only compensate for
the loss of H
+ channel function.
One must also consider the possibility that polyprotein
processing defects, and not loss of p7 function per se, is the reason
for failure of p7 mutants to produce virus. It has been shown that
the K33A/R35A channel inactive mutant results in inefficient
processing of the polyprotein within the E2-p7-NS2 region ([16]
and S. Griffin, unpublished). This can then lead to the
accumulation of E2-p7, p7-NS2 or E2-p7-NS2 fusion proteins or
possibly inadequate levels of mature p7 protein. While it is certain
that the K33A/R35A protein is channel defective, we cannot rule
out the possibility that the defects in this phenotype also result
from aberrant processing. However p7 is still detectable within
cells infected with these viral constructs, albeit at reduced levels (S.
Griffin, unpublished). This reduction in p7 levels could thus
explain the low level complementation achieved with either M2 or
bafilomycin A1 compared to wild-type infection, i.e. there would
be less p7 available to perform its non-ion channel functions which
are necessary to make virus particles.
While the step at which acidification suppresses HCV virus
production remains unclear, our findings as well as others, argue
that the pH sensitive step occurs after virus entry and prior to the
assembly of functional virus. M2 is required for virus disassembly
in the endosomes and for equilibrating the intra-luminal pH of the
trans-Golgi network (TGN) with the cytoplasm. It has also been
demonstrated that the over-expression of M2 from particular
influenza strains, induces luminal dilation of the Golgi and TGN
as well as delayed transport through the secretory pathway in a
similar fashion as monensin [34], suggesting that M2 ion channel
activity functions at the TGN to keep the pH above the threshold
at which HA conformational changes occur. Like M2, p7 has been
suggested to also protect nascent HCV virions from premature
acid-induced conformational changes. This is supported by the
fact that M2 was able to complement a channel defective HCV
and rescue virus production. While p7 has not been directly
connected to membrane rearrangement or organelle disruption,
we cannot rule out the possibility that p7-induced membrane
alterations play a role in virus production.
It has further been observed that p7 channel defective mutations
have quantitatively different effects depending on the parent viral
sequence and/or genotype as well as the expression system [16].
Our results in genotype HJ3-5 chimeric virus, in which the p7
sequence is derived from genotype 1a, show that the K33A/R35A
mutation completely abrogates infectious virus production and can
be partially restored by bafilomycin A1. However, in the context of
JC1, in which the p7 sequence is derived from genotype 2a, the
K33A/R35A mutation results in only a 2-log reduction in
infectious virus [16]. This emphasizes the importance of strain-
dependence in determining the precise quantitative consequence
of p7 defects. Overall, all data agrees that p7 is vital and our new
data clearly show that the channel activity is important, yet other
effects such as processing defects and loss of protein-protein
interactions can contribute to the specific phenotype of p7
mutations in different viral stains and culture systems.
The step at which acidification suppresses HCV virus production
is not yet clear. The most widely cited hypothesis, based on analogy
to influenza[12,13]and other viruses, is that p7 protects the nascent
virus from premature acid-induced conformational changes. Our
finding of acid sensitivity of intracellular but not extracellular virus
suggests it occurs at a step prior to final virion exocytosis. We were
not able to detect infectious intracellular virus in p7KR electropo-
ration and we observed only minimal effects of even high doses of
amantadine on the ratio of intracellular to extracellular virus. These
observations argue that the pH sensitive step may alsooccur early in
the formation of intracellular infectious viral particles and not solely
at the final exocytosis step.
In conclusion, we have specifically shown that p7 dramatically
alters the pH equilibration in intracellular vesicles and causes a loss
of acidification of multiple compartments in live cells. Intracellular
virus itself is acid sensitive and virus production by a p7 mutant
with defective channel function can be partially rescued by using
alternative approaches to prevent intracellular acidification. This
definitively demonstrates that p7 functions as an H
+ channel in
native intracellular membranes and links p7-induced pH changes
to the production of infectious intracellular viral particles. While
p7 channel inhibitors have yet to demonstrate clinical efficacy in
the treatment of hepatitis C, our work shows that amantadine is
ineffective at the concentrations achieved clinically and thus
improved agents targeting the p7 channel activity could have
therapeutic potential. These novel aspects and approaches to
HCV will undoubtedly reveal new details of HCV-host interac-
tions as well as therapy, as more is uncovered about the roles of
this viroporin in virus assembly and release.
Materials and Methods
Materials
General materials were purchased from Sigma-Aldrich (St.
Louis, MO) or Fisher Scientific (Pittsburgh, PA). Dulbecco’s
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glutamine, sodium pyruvate and geneticin were purchased from
Mediatech (Manassas, VA). Penicillin-streptomycin, MEM non-
essential amino acids, Opti-MEM, lipofectamine 2000, DPX (p-
xylene-bis-pyridinium bromide), LysoSensors Yellow/Blue DND-
160 and Green DND-189 and LysoTracker Red DND-99 were
purchased from Invitrogen (Carlsbad, Ca). Protease inhibitor
cocktail (Sigma-Aldrich, P8340) was used at 1:100 dilution.
Amantadine hydrochloride (A1260), rimantadine hydrochloride
(390593), 5-(N, N-Hexamethylene) amiloride (HMA, A9561),
bafilomycin A1 (B1793), monensin and nigericin were purchased
from Sigma-Aldrich. Monoclonal antibody C7-50 to core protein
was purchased from Affinity BioReagents and CellTiter-Blue was
purchased from Promega (Madison, WI).
Plasmids
The plasmids pcDNA-FLAGp7 and pcDNA-FLAGp7KR were
described previously [15,20]. Both contain the p7 sequence from the
J4 infectious clone of HCV genotype 1b and an N-terminal FLAG
tag. The pcDNA-JFH1p7 and pcDNA-JFH1p7R33A/R35A (p7RR)
plasmids are similar channel active and inactive p7 expression
plasmids containing the p7 sequence derived from the JFH1 clone of
HCV genotype 2a. They were constructed identically to the J4
plasmids (primers available on request) introducing an N-terminal
FLAG tag by QuikChange mutagenesis (Stratagene, La Jolla, CA).
The parental HJ3-5 HCV plasmid, (pH-(NS2/NS3)-J/YH/QL) has
been described previously [18]. The p7KR33/35AA and Dp7 (a.a.
2580-2675) mutations were introduced into the pHJ3-5 plasmid
resulting in pHJ3-5(KR) and pHJ3-5(Dp7) using QuikChange
mutagenesis. The pcDNA-based plasmid expressing the HPAI Hong
Kong ’97 156 M2 protein was kindly provided by Wendy Barclay
(Imperial College, London) and described previously [35]. The
region encoding M2 was excised from this plasmid and cloned into
pLVX-IRES-mCherry (Clontech) to yield mCherry-M2, respective-
ly. The channel inactive mCherry-M2(A30P) [27] was created using
QuikChange mutagenesis (Stratagene, La Jolla, CA). All sequences
were confirmed by DNA sequencing analysis.
Cell Culture and Transfection
Human embryonic kidney (HEK) 293FT cells were routinely
cultured in DMEM containing 10% fetal bovine serum, 100 IU/
ml penicillin, 100 mg/ml streptomycin, 0.1 mM MEM non-
essential amino acids, 6 mM L-glutamine, 1 mM MEM sodium
pyruvate, and 500 mg/ml geneticin. Genome-length and sub-
genomic genotype 1a HCV replicon cell lines were described
previously [25,36]. Full-length and sub-genomic replicon-bearing
cells were cultured in DMEM supplemented with 10% fetal bovine
serum, 100 IU/ml penicillin, 100 mg/ml streptomycin, 2 mg/ml
blasticidin (Invitrogen) and 200 mg/ml geneticin. Full-length
replicon cells were ‘‘cured’’ by culturing with interferon-a
(200 U/ml for 4 weeks). Media used for the culture of cured
replicon cell lines contained no geneticin. All transfections were
carried out using Lipofectamine 2000 (Invitrogen). pcDNA-
FLAGp7 was transfected into the cells according to the
manufacturer’s instructions. Due to expression variability,
pcDNA-FLAGp7KR needed to be transfected using 1/3 the
DNA concentration of wild-type pcDNA-FLAGp7 to achieve
equal protein expression levels. Transfection complexes were
incubated with the cells for 24 h in Opti-MEM serum-free
medium (Invitrogen) before harvesting.
RNA Transcription, Electroporation and HCV Infectivity
RNA was synthesized with T7 MEGAScript reagents (Ambion)
as in Kato et al. [37] and transfected into Huh-7.5 cells by
electroporation. Briefly, 10 mg of RNA was mixed with 5610
6 cells
suspended in 250 ml of Opti-MEM media, in a cuvette with a gap
width of 0.2 cm (Bio-Rad). Electroporation consisted of one pulse
of current delivered by the Gene Pulser Xcell electroporation
device (Bio-Rad), set at 140 V, 1000 mF, and maximum resistance.
Electroporated cells were plated in complete media (DMEM
supplemented with 10% fetal bovine serum, 100 IU/ml penicillin,
100 mg/ml streptomycin and 1X nonessential amino acids).
Culture medium was replaced after 24 h.
For the bafilomycin A1 rescue experiments, Huh-7.5 cells were
electroporated with parental HJ3-5, HJ3-5(KR), or HJ3-5(Dp7)
viral RNA and equally seeded into 2 wells of a 6-well plate. At
96 h post-electroporation, the culture medium was removed and
replaced with fresh, complete media containing 2.5 pM bafilomy-
cin A1. Following an additional 24 h of incubation, supernatant
medium and cell lysates were collected and assayed for infectivity.
The presence of infectious HCV particles was measured by
calculating focus-forming units per ml virus (FFU/ml) with various
dilutions as described below. In undiluted samples, no attempt was
made to remove bafilomycin from medium or lysates.
To assay viral titers, 100 ml aliquots of serial 10-fold dilutions of
supernatant cell culture fluids (clarified by low-speed centrifuga-
tion) were inoculated onto naı ¨ve Huh-7.5 cells seeded 24 h
previously into 8-well chamber slides (Nalge Nunc) at 2610
4 cells/
well. Intracellular virus was isolated by freeze-thaw of cell lysates.
Briefly, infected cells were washed in PBS, dislodged from the
tissue culture flask with trypsin, brought to 5.0 ml with complete
media and centrifuged at 4006g for 5 min at 4uC. The cell pellet
was resuspended in 1.0 ml DMEM and subjected to 4 cycles of
freeze and thaw using a methanol/dry ice bath and a 37uC water
bath. Samples were then centrifuged at 10,0006g for 10 min at
4uC to remove cell debris. After inoculation, cells were maintained
at 37uC, 5% CO2 and fed with 200 ml of medium 24 h later.
Following 48 h additional incubation, cells were fixed in 1:1
methanol-acetone at room temperature for 10 min, then incubat-
ed with monoclonal antibody C7-50 to core protein (Affinity
BioReagents, 1:300) for 2 h at RT, washed with PBS twice, and
incubated with Alexa Fluor 488-conjugated goat anti-mouse
secondary antibody (Invitrogen, 1:500) for 1 h at RT. Infectivity
was determined by calculating focus-forming units per ml of
original culture medium or cell lysate (FFU/ml).
Subcellular Fractionation and Isolation of Membrane
Vesicles
293FT cells were dislodged from the tissue culture flask into ice-
cold phosphate-buffered saline (PBS) and centrifuged at 1,0006g
for 10 min at 4uC followed by two more washes in PBS. HCV
replicon cells were dislodged by incubating with pre-warmed cell
dissociation solution (Sigma, C5914) for 15 min followed by three
washes in PBS. The cell pellet was resuspended in 1.0 ml of
homogenization media (250 mM sucrose, 1 mM EDTA, 20 mM
HEPES [pH 7.4], 2 mM MgCl2, protease inhibitors) and
homogenized on ice using 25 strokes of a loose-fitting Dounce
homogenizer until ,95% of the cells were disrupted. Homoge-
nates were cleared of nuclei and unbroken cells by centrifuging at
1,0006 g for 10 min at 4uC. For vesicle isolation, the 1,0006 g
supernatant was centrifuged at 10,0006 g for 15 min at 4uCt o
remove all heavy membranes. The resultant supernatant was
centrifuged at 120,0006g in a MLS-50 swinging bucket rotor for
1 h at 4uC to pellet membrane vesicles. Vesicles were resuspended
in homogenization buffer, flash frozen in liquid nitrogen and
stored in 100 mg aliquots at 280uC until needed for conductance
assays. For gradient analysis, the 1,0006 g supernatant was
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mitochondria and plasma membrane fragments.
Western Blotting
Western blotting was performed using anti-Flag M2, 1 mg/ml
(Sigma-Aldrich), anti-PDI, 1:2,000 (Stressgen, Victoria, BC,
Canada), anti-GRP75, 1:20 (Affinity Bioreagents, Golden, CO),
anti-LAMP2 H4B4, 1:2,000 (DHSB, University of Iowa), anti-
core, 1:1,000 (Affinity Bioreagents) and anti-b-actin, 1:15,000
(Sigma-Aldrich). Horseradish peroxidase-conjugated secondary
antibodies were from Pierce Biotechnologies (Rockford, IL).
Immunoblots were detected using the ECL Plus Western Blotting
Detection System (Amersham Biosciences, Piscataway, NJ).
Measurement of Proton Permeability
Isolated vesicles (200 mg) were thawed on ice, brought to 1.0 ml
with conductance assay buffer (10 mM MOPS [pH 7.0], 150 mM
KCl, 4 mM MgSO4) containing 5 mM HPTS (8-hydroxypyrene-
1,3,6-trisulfonic acid, trisodium salt, Invitrogen) and broken and
resealed with 10 strokes of a loose-fitting Dounce homogenizer to
incorporate HPTS into the vesicle lumen. To separate HPTS-
loaded vesicles from extra-vesicular free dye, re-homogenized
vesicles were applied to a 5 ml Bio-Gel P-10 size exclusion
column, with a 20 kD exclusion limit prepared as according to
manufacturer’s instructions (Bio-Rad). The column was eluted
using HPTS-free conductance assay buffer. Fractions were
collected and assayed for protein and HPTS fluorescence at ex
450 nm, em 520 nm. Protein containing fractions eluting in the
void volume corresponded to a small fluorescence peak and
represented HPTS-loaded vesicles. These were pooled and used
for conductance assays. Protein concentration within the fractions
was assayed using Bio-Rad protein assay dye reagent.
Vesicular proton permeability was measured by a modification of
the method described by Grover et al. [38]. Fluorescence
measurements were performed at room temperature in a Fluostar
Optima plate reader equipped with an integrated syringe injector
(BMG Labtech, Durham, NC). The excitation wavelengths were
450 nm (pH-dependent) and 405 nm (pH-independent) and data
were collected every 1 s for 4 min at an emission wavelength of
520 nm. To determine changes of intravesicular pH, HPTS-loaded
vesicles were diluted in HPTS-free conductance assay buffer,
allowed to equilibrate at room temperature for 30 min, and
subsequently pipetted into a 96 well plate, 100 ml per well.
Fluorescence of the vesicle suspension was monitored and once a
stable baseline was achieved, 10 ml of 50 mM KOH was injected
per well while the plate was stirred and the fluorescence was
monitored. The addition of base alkalinized the extra-vesicular
environment from pH 7.0 to 8.0 as confirmed with a pH meter.
Ionophore and inhibitor compounds were added to the vesicle
suspension just prior to reading. Intravesicular pH was calculated
from the fluorescence ratio using a bulk solution extracellular
calibration curve performed with a conventional pH meter. In some
experimentsanyextravesicular fluorescencesignalwasquenched by
addition of 15 mM p-xylene-bis-pyridinium bromide (DPX).
Live Cell Imaging of Vesicular pH
HCV replicon bearing, infected or electroporated cells were
plated on poly-D-lysine coated cover slips and allowed to grow
overnight. The cells were then washed in HEPES solution (10 mM
HEPES, 133.5 mM NaCl, 2.0 mM CaCl2, 4.0 mM KCl, 1.2 mM
MgS04, 1.2 mM NaH2PO4, 11 mM glucose; pH 7.4) and loaded
with 5 mM LysoSensor Yellow/Blue DND-160 diluted in HEPES
solution at 37uC for 45 min. The cells were washed twice and
immediately imaged. Imaging was performed using a Nikon
eclipse Ti PFS Quantitative Fluorescence Live-Cell and Multidi-
mensional Imaging System equipped with a digital monochrome
Coolsnap HQ
2 camera (Roper Scientific, Tucson, AZ). Fluores-
cence images were collected using Metafluor software (Universal
Imaging, Downingtown, PA). Data were recorded at excitation/
emission wavelengths of 340/440 nm and 380/510 nm using a
410 nm dichroic.
Cell fluorescence ratios were determined by image analysis of
the stored single wavelength images using Metafluor software. For
each cell a region of interest was delineated that encompassed the
cytosolic space of the cell and excluded the nucleus. Ratio was
calculated for each cell as R=(F1-B1)/(F2-B2) where F1 and F2 are
the fluorescence intensities at 380/525 and 340/440 respectively
and B1 and B2 are the corresponding background values
determined from a region on the same images that was near the
cell but did not contain a cell.
Calibration of the relationship between R values and pH was
performed by two different methods. First, a free solution calibration
was performed using LysoSensor solutions of known pH and
measuring R with the microscope as described. The calibration
curve was well fitted by the equation pH = ln[(R-Yo)/a] ?1/b,
where Yo, a and b are constants. Anintracellular calibration was also
performed as described elsewhere [39]. Cells were loaded with
LysoSensor and then permeabilized with 10 mM monensin and
10 mM nigericin. They were then serially exposed to calibration
buffer solutions containing 25 mM MES, 5 mM NaCl, 115 mM
KCl and 1.2 mM MgSO4 at fixed pH and R was measured as
described. The 2 methods agreed well. The ionophores, however,
resulted in loss of LysoSensor from intracellular vesicles at higher
pH. This resulted in very low signals above pH 5.5 and made the
intracellular calibration method impractical except for use at the
most acid pH range. For this reason, the free solution calibration
was used in most experiments. R values were converted to pH by
extrapolation of the calibration curve.
For experiments to determine the concentration dependence of
bafilomycin on vesicular pH, Huh-7.5 cells were plated on poly-D-
lysine coated cover slips and allowed to grow overnight, after
which time the cells were washed in HEPES solution and loaded
with 2 mM of the single wavelength pH indicator LysoSensor
Green DND-189 for 30 min at 37uC. The cells were washed,
treated with HEPES 6 increasing concentrations of bafilomycin
A1 and immediately imaged. The increase in vesicular pH in
response to increasing concentrations of bafilomycin A1 was
determined by imaging at excitation of 443 nm and emission at
500 nM.
Measurement of Acidic Compartments in Fixed Cells
Cells, approximately 5000, were plated on 12 mm polylysine
coated glass cover slips and incubated overnight. The cells were
then washed in HEPES solution and loaded with 0.5 mM
LysoTracker Red DND-99 in HEPES solution for 30 min at
37uC. The cells were washed in PBS, fixed in 4% paraformalde-
hyde for 30 min at room temperature, permeabilized in ice-cold
acetone for 5 min and incubated in IF buffer (1% BSA, 2.5 mM
EDTA in PBS) for 1 hr at room temperature. HCV core protein
was labeled by incubating with anti-core, 1:300, as described
above. Nuclei were counterstained by incubation for 5 min with
1.0 mg/ml DAPI and the cover slips were mounted in Fluorsave
mounting medium (Invitrogen). LysoTracker positive staining was
quantitated by image analysis in a Nikon TiE system as described
above. Single wavelength fluorescence images were acquired at
560 nm excitation, 607 nm emission. A region of interest was
chosen to include the entire area of a single cell. Images were
acquired at fixed detector gain that avoided saturation in the
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determined and reported as mean cellular fluorescence intensity.
Cytotoxicity of Bafilomycin
Huh-7.5 cells were plated in 96-well tissue culture plates at
10,000 cells per well and allowed to grow overnight after which
time the cells were washed with PBS and the medium was replaced
with fresh compete medium containing varying concentrations of
bafilomycin A1 for 24 h. The cells were then washed in PBS and
fresh DMEM containing 10% CellTiter-Blue reagent (Promega)
was added. After 3 h incubation at 37uC, 5% CO2, the
fluorescence at 560/590 nm was read in a Fluostar Optima plate
reader.
Effect of Bafilomycin A1 on Viral Entry
Huh-7.5 cells (2610
4 cells) were plated in the wells of an 8-well
chamber slide and incubated overnight. The cells were then
washed in PBS and incubated at 37uC, 5%CO2 in complete media
containing varying concentrations of bafilomycin A1 for 1 hr. The
media was then removed and the cells were infected with 0.5 ml
complete media containing HJ3-5 virus (MOI 1.0) 6 bafilomycin
A1 and incubated at 37uC, 5% CO2 for 3 hr. The inoculum was
then removed, the cells were washed in PBS and fresh complete
media was added. Following an additional 72 hr incubation,
infected cells were fixed by methanol:acetone (1:1), stained for core
protein and foci counted as described above.
M2 Trans-complementation
Huh-7.5 cells (2.5610
6) were co-electroporated with 20 mg
mCherry-M2 or mCherry-M2(A30P) DNA and 10 mg JFH-1
derived RNAs as described previously. The electroporated cells
were resuspended into 5 ml complete media and seeded into two
wells of a 6-well plate. After 48 hr, the cells were re-transfected with
20 mg mCherry-M2 or mCherry-M2(A30P) using lipofectamine
according to manufacturer’s instructions. 24 hr after transfection,
the media was removed and fresh, complete media 650 mM
amantadine was added for an additional 24 hr. Secreted infectivity
was quantified by focus forming assay by infecting 2610
4 naı ¨ve
Huh-7.5 cells seeded the preceding day in an 8-well chamber slide.
Infected cells were fixed by methanol:acetone (1:1), stained for core
protein and foci counted as described above.
Low pH Treatment of Extracellular and Intracellular Virus
Huh-7.5 cells were plated in a T-175 cm
2 culture dish and
infected with cell culture passaged JFH-1 virus at an MOI of 1.0.
After five days, the cell supernatant fluids were collected and
clarified by low-speed centrifugation. Intracellular virus was
obtained by freeze-thaw of washed cellular pellets as described
above. Extracellular and intracellular viral stocks were then
identically diluted 1:1 in a HEPES/MES buffer (20 mM HEPES,
20 mM MES, 133.5 mM NaCl, 2.0 mM CaCl2, 4.0 mM KCl,
1.2 mM MgS04, 11 mM glucose; pH 7.4) at pH 2.1, 2.6, 5.3, or
7.0. The final pH values of the virus/buffer solutions were 4.0, 5.0,
6.0, and 7.0 respectively. The virus/buffer suspensions were
incubated in a 37uC water bath for 10 min and then neutralized
with 1M NaOH. The samples were then clarified by low-speed
centrifugation at 5006 g for 5 min and diluted 1:10 or 1:100 in
complete media. Infectivity was determined by calculating focus-
forming units per ml of original culture medium or cell lysate
(FFU/ml).
Statistics
Results are expressed as mean 6 SE. The Student t test was
used for statistical analyses. P#0.05 was considered significant.
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